雄激素受体异常的临床试验
总计1438个结果
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)招聘中解剖学 IV 期乳腺癌 AJCC v8 | 预后 IV 期乳腺癌 AJCC v8 | 雌激素受体阳性 | HER2/Neu 阴性 | 孕激素受体阳性 | 升高的 CA15-3 或 CEA 或 CA27-29美国, 波多黎各, 关岛
-
Ohio State University Comprehensive Cancer CenterAmerican Cancer Society, Inc.完全的
-
Uppsala University HospitalUppsala University; Swedish Society for Medical Research招聘中
-
Johns Hopkins UniversityUniversity of Utah; Integra LifeSciences Corporation完全的
-
University of WashingtonNational Cancer Institute (NCI)终止
-
National Cancer Institute (NCI)National Institutes of Health (NIH)完全的
-
Medical University of ViennaUniversity of Mississippi Medical Center完全的
-
University of WashingtonMerck Sharp & Dohme LLC撤销转移性乳腺癌 | 三阴性乳腺癌 | 复发性乳腺癌 | 雌激素受体阴性 | HER2/Neu 阴性 | 孕激素受体阴性美国
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)完全的晚期恶性实体瘤 | 复发性乳腺癌 | 雌激素受体阳性 | HER2/Neu阳性 | 孕激素受体阳性 | IV 期乳腺癌 AJCC v6 和 v7 | 绝经后 | IIIA 期乳腺癌 AJCC v7 | IIIB 期乳腺癌 AJCC v7 | IIIC 期乳腺癌 AJCC v7 | 难治性乳腺癌 | 绝经前 | 难治性激素受体阳性乳腺癌美国
-
National Cancer Institute (NCI)完全的
-
University of VirginiaEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)完全的
-
Taipei Medical University完全的
-
Second Affiliated Hospital, School of Medicine,...Westlake University未知
-
Translational Research Center for Medical Innovation...Johnson & Johnson; Codman & Shurtleff; Eisai Limited; Nihon Medi-Physics Co., Ltd.; Daiichi Pharmaceuticals完全的
-
ETOP IBCSG Partners FoundationNational Cancer Institute (NCI); NCIC Clinical Trials Group; Cancer and Leukemia Group B; North... 和其他合作者主动,不招人复发性乳腺癌 | IIIA期乳腺癌 | IA期乳腺癌 | IB 期乳腺癌 | IIA期乳腺癌 | IIB期乳腺癌 | 雌激素受体阳性乳腺癌 | 孕激素受体阳性肿瘤美国, 加拿大, 瑞士